MedErgo: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedErgo
Largest movements
- Cash -€29,605
down €29,605 (-59.9%), from €49,413 to €19,808
mainly Contributions, distributions and other (-€24,336) and Other debts (-€15,480)
- Other debts -€15,480
down €15,480 (-62.4%), from €24,816 to €9,336
- Profit (loss) carried forward -€15,356
no longer reported in 2025 (was €15,356)
- Tax, wage and social debts +€1,330
up €1,330 (+38.4%), from €3,461 to €4,791
- Gross operating margin +€3,075
up €3,075 (+31.7%), from €9,686 to €12,761
- Taxes +€889
up €889 (+35.9%), from €2,474 to €3,364
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €49,832 | €20,327 | -€29,505 | -59.2% |
| Current assets | 29/58 | €49,832 | €20,327 | -€29,505 | -59.2% |
| Amounts receivable within one year | 40/41 | €419 | €519 | +€100 | +23.8% |
| Trade receivables | 40 | €131 | €131 | = | 0.0% |
| Other amounts receivable | 41 | €289 | €389 | +€100 | +34.5% |
| Cash at bank and in hand | 54/58 | €49,413 | €19,808 | -€29,605 | -59.9% |
| Total equity and liabilities | 10/49 | €49,832 | €20,327 | -€29,505 | -59.2% |
| Equity | 10/15 | €21,556 | €6,200 | -€15,356 | -71.2% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €15,356 | - | -€15,356 | |
| Amounts payable | 17/49 | €28,276 | €14,127 | -€14,150 | -50.0% |
| Amounts payable within one year | 42/48 | €28,276 | €14,127 | -€14,150 | -50.0% |
| Taxes, remuneration and social security | 45 | €3,461 | €4,791 | +€1,330 | +38.4% |
| Taxes | 450/3 | €3,461 | €4,791 | +€1,330 | +38.4% |
| Other amounts payable | 47/48 | €24,816 | €9,336 | -€15,480 | -62.4% |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | €9,686 | €12,761 | +€3,075 | +31.7% |
| Operating profit (loss) | 9901 | €9,302 | €12,374 | +€3,072 | +33.0% |
| Financial charges | 65/66B | €30 | €30 | = | 0.0% |
| Recurring financial charges | 65 | €30 | €30 | = | 0.0% |
| Profit (loss) for the period before taxes | 9903 | €9,272 | €12,344 | +€3,072 | +33.1% |
| Income taxes | 67/77 | €2,474 | €3,364 | +€889 | +35.9% |
| Profit (loss) for the period | 9904 | €6,797 | €8,980 | +€2,183 | +32.1% |
| Profit (loss) for the period to be appropriated | 9905 | €6,797 | €8,980 | +€2,183 | +32.1% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.